Data updated: Mar 29, 2026
ARTESUNATE
ARTESUNATE
Approved 2020-05-26
1
Indication
--
Phase 3 Trials
1
Priority Reviews
5
Years on Market
Details
- Status
- Prescription
- First Approved
- 2020-05-26
- Routes
- INTRAVENOUS
- Dosage Forms
- POWDER
ARTESUNATE Approval History
Loading approval history...
What ARTESUNATE Treats
1 FDA approvalsOriginally approved for its first indication in 2020 .
- Other (1)
🔬
Pro Active Pipeline
Ongoing clinical trials by development phase
Loading...
⭐
Pro Key Completed Trials
Completed studies with published results, ranked by significance
Loading...
📊
Trial Timeline
Full development history with FDA approval milestones
|
Loading...
Understanding FDA Approval Types
| Count | Type | What it means |
|---|---|---|
| - | ORIG | Original approval - drug first enters market |
| - | SUPPL - Efficacy | New indication (new disease/condition approved) |
| - | SUPPL - Labeling | Label text changes (warnings, dosing updates) |
| - | SUPPL - Manufacturing | Production changes (new facility) |
| - | SUPPL - Chemistry | Formulation changes (new dosage strength) |
Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.
ARTESUNATE FDA Label Details
ProARTESUNATE Patents & Exclusivity
Latest Patent: Feb 2044
Exclusivity: May 2027
Patents (1 active)
US12121506
Expires Feb 16, 2044
Exclusivity
ODE-290
Until May 2027
Source: FDA Orange Book
Want competitive intelligence?
See who's developing similar drugs and track their progress
Data Sources
Data sourced from official FDA and NIH databases. Click links to verify on original sources.